Dihydroergotoxin Methanesulfonate en es it fr

Dihydroergotoxin Methanesulfonate Brand names, Dihydroergotoxin Methanesulfonate Analogs

Dihydroergotoxin Methanesulfonate Brand Names Mixture

  • No information avaliable

Dihydroergotoxin Methanesulfonate Chemical_Formula

C33H45N5O5

Dihydroergotoxin Methanesulfonate RX_link

No information avaliable

Dihydroergotoxin Methanesulfonate fda sheet

Dihydroergotoxin Methanesulfonate msds (material safety sheet)

Dihydroergotoxin Methanesulfonate Synthesis Reference

No information avaliable

Dihydroergotoxin Methanesulfonate Molecular Weight

591.741 g/mol

Dihydroergotoxin Methanesulfonate Melting Point

No information avaliable

Dihydroergotoxin Methanesulfonate H2O Solubility

No information avaliable

Dihydroergotoxin Methanesulfonate State

Solid

Dihydroergotoxin Methanesulfonate LogP

2.615

Dihydroergotoxin Methanesulfonate Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Dihydroergotoxin Methanesulfonate Indication

For use as an adjunct therapy for patients with dementia

Dihydroergotoxin Methanesulfonate Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Dihydroergotoxin Methanesulfonate Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Dihydroergotoxin Methanesulfonate side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Dihydroergotoxin Methanesulfonate Patient Information

No information avaliable

Dihydroergotoxin Methanesulfonate Organisms Affected

Humans and other mammals